Stock Market News for January 12, 2026
768 news published.
AI, diagnostics and enterprise tech partnerships
NVIDIA (NVDA) doubled down on life‑sciences AI, announcing a co‑innovation AI lab with Eli Lilly to speed drug discovery and revealing broader industry uptake as the BioNeMo platform is adopted by leading life‑sciences firms. These moves cement NVIDIA’s positioning in AI‑driven R&D and signal growing demand for GPU‑accelerated models across biopharma.
Natera (NTRA) said it will scale AI foundation models with NVIDIA to enhance precision‑medicine capabilities—an example of diagnostics players embedding large models to improve variant interpretation and clinical workflows.
Personalis (PSNL) launched a Real‑Time Variant Tracker™ for MRD testing, a practical step toward faster, actionable monitoring for oncology trials and clinicians.
Digi Power X (DGXX) remains relevant after its $20 million NVIDIA B300 GPU order, illustrating enterprise demand for GPU‑as‑a‑Service capacity across sectors.
MKS Inc. (MKSI) unveiled photonics solutions aimed at accelerating AI, quantum and biotech compute at Photonics West, underscoring supply‑chain momentum for next‑gen hardware that supports model scaling and specialized instrumentation. (details)
Healthcare, diagnostics and regulatory wins
Biogen (BIIB) picked up a regulatory win as the European Commission approved a high‑dose SPINRAZA® regimen, expanding dosing options and European revenue visibility for the neuromuscular franchise.
Solid Biosciences (SLDB) received FDA orphan drug designation for SGT‑212, a regulatory milestone for its dual‑route gene therapy targeting Friedreich’s ataxia that could accelerate development incentives and trial support.
Charles River Laboratories (CRL) provided business updates highlighting demand in preclinical and early‑stage services, useful context for investors modeling contract flows and margins in the CRO space. (update)
Option Care Health (OPCH) posted preliminary Q4 and FY‑2025 results and guidance for 2026, offering an early read on home‑infusion volumes and margin dynamics for payers and providers.
Avadel Pharmaceuticals (AVDL) cleared a key step as shareholders approved the proposed acquisition by Alkermes; the vote lowers deal execution risk and tightens strategic options for the product portfolio. (shareholder approval)
Consumer, retail and travel updates
American Eagle Outfitters (AEO) reported record holiday sales, a read‑through for mall‑centric apparel peers on inventory and comps.
Chipotle (CMG) is testing demand sensitivity with a one‑day free double protein promo, an experiment investors will watch for traffic and margin tradeoffs.
Wayfair (W) struck a notable partnership with Google to advance AI‑powered shopping for the home, a move that could boost personalization, search integration and conversion for e‑commerce sales.
Energy, materials and industrials
Elevra Lithium (ELVR) announced an accelerated NAL expansion, a development that investors will watch for timing on incremental supply and potential pricing impacts in the lithium market.
Planet Labs (PL) secured a nine‑figure contract with Sweden, a material commercial win that should boost backlog and subscription revenue for imagery analytics.
Satellogic (SATL) signed an $18 million deal to deliver two satellites to Portugal, expanding international footprint.
Corporate governance, M&A and capital moves
S&P Global (SPGI) completed the sale of EDM and thinkFolio, refocusing on data and analytics and freeing capital for higher‑return initiatives.
Warner Bros. Discovery (WBD) received renewed outreach from Paramount on a $30 per share all‑cash offer, injecting fresh M&A pressure into media valuations and strategic options.
OpenText (OTEX) completed the divestiture of a non‑core unit for $163 million, a tidy disposal that sharpens focus on core enterprise content and information management services. (details)
OneSpan (OSPN) agreed to acquire Build38 to bolster mobile app protection—an acquisition that strengthens OneSpan’s security stack and addresses rising demand for app‑level threat mitigation. (deal)
Financing, earnings calendars and sector notes
Companies updating calendars or setting calls today include Revvity (RVTY), which will hold its earnings call on Feb. 2, and insurers like Assurant (AIZ), which announced plans to release Q4 and FY‑2025 results; both are near‑term catalysts for sector‑specific guidance and margin signals.
Wealthfront (WLTH) reported record total revenue of $93.2 million and net income of $30.9 million for fiscal Q3 2026, a milestone showing stronger monetization and scale in the robo/advisory space. (financials)
Matthews International (MATW) announced a notice of redemption for its 8.625% senior secured second lien notes due 2027, a capital‑structure move to watch for leverage and refinancing impacts. (notice)
SolaREIT (AUB) expanded its revolving credit facility to $80 million, strengthening liquidity for portfolio investments and development activity reported earlier.
Selected mid‑cap and smaller updates investors should note
- Alignment Healthcare (ALHC) reported 31% Y/Y membership growth to 275,300, strengthening revenue visibility for value‑based Medicare plans.
- Schrödinger (SDGR) outlined 2026 strategic priorities tied to platform commercialization.
- Nyxoah (NYXH) released preliminary Q4 and FY‑2025 results and gave Q1 2026 revenue guidance, a short‑term read on device adoption in sleep apnea markets. (update)
- SMX (SMX) was featured on MSN for breakthrough precious‑metals tracking technology, a visibility boost for a niche supply‑chain play. (coverage)
- Piedmont Realty Trust (PDM) reported it leased 2.5 million sq. ft. in 2025, a sign of continued industrial demand in its markets.
Defense, space and infrastructure wins
Planet Labs (PL) secured a nine‑figure contract with Sweden, a material commercial win that should boost backlog and subscription revenue for imagery analytics.
Satellogic (SATL) signed an $18 million deal to deliver two satellites to Portugal, expanding international footprint.
COPT Defense (CDP) mourned the death of former CEO and trustee Roger A. Waesche Jr.; while not a market catalyst, leadership passings can affect governance and investor relations. (notice)
What to watch next
Monitor follow‑up details from the NVIDIA–Lilly lab and BioNeMo adopters for partnership or procurement announcements that could move chip and cloud vendors. In healthcare, watch Solid Biosciences’ regulatory pathway and Charles River’s contract cadence for CRO demand signals. Keep an eye on earnings dates from Revvity and Assurant for sector guidance, and on Elevra’s NAL expansion for lithium supply implications. Expect this dispatch to be reorganized as material earnings, trial readouts or bigger M&A moves break during the session.
Stay ahead of the market with our list of today's most important stock news and financial updates. Whether you're a day trader, long-term investor, or market enthusiast, our news feed covers everything you need to know about publicly traded companies.
Our news feed is designed for investors who want to stay informed about the latest developments affecting their portfolio or watchlist. Whether you're researching potential investments, monitoring your current holdings, or simply staying up-to-date with market trends, our stock news page provides the information you need to make informed decisions.
What You'll Find on This Page:
- Breaking financial news and market-moving headlines
- FDA approvals and clinical trial results for biotech and pharma stocks
- Stock offerings, dividends, and other corporate actions
- Mergers, acquisitions, and strategic partnerships
- Business news affecting company performance and stock prices
- Easy-to-use tags for quick news categorization
- Stock tickers for instant company identification
- AI sentiment analysis to gauge market reaction
- Estimated impact scores to assess potential stock movement